Carbamazepine Tablet, Extended Release
Product Images NDC 16571-682

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 16571-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (Label100)

This is a description for Carbamazepine Extended-Release Tablets, a medication that should be taken by swallowing it whole and not chewed or crushed. It is recommended that the accompanying Medication Guide be given to each patient. It is imperative to keep in a dry place, away from reach of children. The tablet contains Carbamazepine USP 100mg and manufactured by ADW 01,8 Chemicals & Pramaceutcas Ltd in Mumbai, India. The tablets must be kept in USP controlled room temperature between 15°-30°C (56°-86°F). The product is distributed by Unique Pharmaceutical Laboratories, and manufactured by Rising Pharma Holdings in East Brunswick, NJ.*

FDA Label Image

200mg (Label200)

This is a description of Carbamazepine Extended-Release Tablets, a medication used for certain types of seizures and nerve pain. The tablets should never be crushed or chewed and come in a 100 tablet container. The medication guide should be given to each patient. The tablets should be kept away from the reach of children and be stored at room temperature. The manufacturing company is ADW01 Chemicals & Pharmaceuticals Ltd in India, and the tablets contain Gabamazzpne 200mg. The dosage should be determined according to the package and dispensed in a tight container. The medication is distributed by Unique Pharmaceutical Laboratories in East Brunswick, NJ.*

FDA Label Image

400mg (Label400)

Carbamazepine is a medication that comes in 100 extended-release tablets. It is manufactured by (ADW 01,8 Chemicals & Pharmaceuticals Ltd) in Mumbai, India and distributed in the US by Rising Pharma Holdings, based in East Brunswick, NJ. Each tablet contains 400 mg of Cabamazzpine USP, and the usual dosage is indicated on the package. It is important to dispense the medication in a USP fight container and to keep it away from moisture. The package includes a Medication Guide to be distributed to each patient. Batch coding and a 2D barcode are included on the packaging.*

FDA Label Image

Logoa (Risinglogo)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.